Flotetuzumab and other T-Cell Immunotherapies Upregulate MHC Class II Expression on Acute Myeloid Leukemia Cells. Rimando JC, Chendamarai E, Rettig MP, Jayasinghe RG, et al. Blood 2022 Dec 23:blood.2022017795. doi: 10.1182/blood.2022017795.

Read + Share

Amedeo Smart

Independent Medical Education

Rimando JC, Chendamarai E, Rettig MP, Jayasinghe RG, et al. Flotetuzumab and other T-Cell Immunotherapies Upregulate MHC Class II Expression on Acute Myeloid Leukemia Cells. Blood 2022 Dec 23:blood.2022017795. doi: 10.1182/blood.2022017795.
PMID: 36563336